MedPath

Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis

Conditions
Rheumatoid Arthritis
Cardiovascular Diseases
Atherosclerosis, Coronary
Registration Number
NCT03813017
Lead Sponsor
Ziv Hospital
Brief Summary

Cardiovascular disease is a leading cause for morbidity and mortality in general population. The incidence of cardiovascular disease and their poor outcome is well documented in a broad spectrum of connective tissue diseases, especially in rheumatoid arthritis (RA). The risk of incident CVD is increased by 48% in patients with RA compared to the general population.

RA is associated with 50% increase in the mortality in patients with cardiovascular disease (CVD). One reason is the more frequent cardiovascular risk factors in RA patients compared with the general population. Patients with RA have a high risk of premature cardiovascular disease (CVD). The aim of the present study is to assess whether there are non-invasive measures that might predict arteriosclerosis in RA patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
100
Inclusion Criteria
  1. 18-70 years old (except for women till 75 years old)

  2. Absence of established CVD:

    • Myocardial Infarction p/h
    • PCI with balloon and/or stent
    • Intermittent claudication
    • PAD / intervention
    • CAS /intervention
  3. Signed informed consent form

  4. Documented diagnosis of rheumatoid arthritis

Exclusion Criteria
  1. Known CVD
  2. Pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cardiovascular disease risks in patient with theumatoid arthritis6 months

Prediction of cardiovascular risks and proposed preventive treatment

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath